Summary
The effect of metformin on hepatocyte insulin receptor binding was examined in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice. In normal mice, chronic administration of metformin (60 mg· kg-1· day-1 for 50 weeks) increased the number of low affinity receptors by 148%. During acute studies, metformin increased (30%) the number of low affinity receptors after 24 h. When metformin was withdrawn after treatment for 96 h, the number of low affinity receptors decreased, approaching control values by 48 h. In severely insulin resistant ob/ob mice, the concentrations of high and low affinity receptors were reduced by 60% and 27%, respectively. A high dose of metformin (240 mg·kg-1·day-1 for 4 weeks) increased the concentration of high and low affinity receptors in ob/ob mice by 63% and 86%, respectively. However, the hypoglycaemic response to exogenous insulin was not altered. In streptozotocin-diabetic mice, the number of low affinity receptors was increased by 68% compared with normal mice. Metformin (60 mg·kg-1·day-1 for 10 weeks) did not significantly alter the number of insulin receptors in streptozotocin-diabetic mice, but the hypoglycaemic response to exogenous insulin was improved by 94%. The results raise the possibility that metformin might affect post-receptor sites of insulin action independently of effects at the receptor level.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Herman LS (1979) Metformin: a review of its pharmacological properties and therapeutic use. Diabete Metab 5: 233–245
Junien JL, Brohon J, Guillaume M, Sterne J (1979) DBM mice as a pharmocological model of maturity onset diabetes. Studies with metformin. Arch Int Pharmacodyn 241: 165–176
Frayn KN, Adnitt PI (1972) Effect of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats. Biochem Pharmacol 21: 3153–3162
Holle A, Mangels W, Dreyer M, Kuhanu J, Rudiger HW (1981) Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes. N Engl J Med 305: 563–566
Vigneri R, Pezzino V, Wong KY, Goldfine ID (1982) Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding to its receptors in target cells. J Clin Endocrinol Metab 54: 95–101
Flatt PR, Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob/ +) mice. Diabetologia 20: 573–577
Bailey CJ, Flatt PR, Atkins TW (1982) Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int J Obesity 6: 11–21
Billingham MS, Hall RA, Simpson S, Bailey CJ (1981) Plasma high density lipoprotein cholesterol in streptozotocin diabetic and non-diabetic mice after prolonged administration of glibenclamide, chlorpropamide and metformin. Diabete Metab 7: 271–274
Stevens JF (1971) Determination of glucose by an automatic analyser. Clin Chim Acta 32: 199–201
Bailey CJ, Ahmed-Sorour H (1980) Role of ovarian hormones in the long-term control of glucose homeostasis: effects on insulin secretion. Diabetologia 19: 475–481
Lennard MS, Casey C, Tucker GT, Woods HF (1978) Determination of metformin in biological samples. Br J Clin Pharmacol 6: 183–185
Kahn CR, Neville DM, Roth J (1973) Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance. J Biol Chem 248: 244–250
Seglen PO (1972) Preparation of rat liver cells. Exp Cell Res 74: 450–454
Roth RA (1981) Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem Biophys Res Comm 98: 431–438
Freychet P, Roth J, Neville DM (1971) Insulin receptors in the liver: specific binding of (125I) insulin to the plasma membrane and its relation to insulin bioactivity. Proc Natl Acad Sci USA 68: 1833–1837
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672
Bailey CJ, Lord JM, Atkins TW (1983) The insulin receptor and diabetes. In: Santiago J, Nattrass M (eds) Recent advances in diabetes. Churchill Livingstone, Edinburgh (in press)
Kahn CR (1975) Membrane receptors for polypeptide hormones. In: Konn ED (ed) Methods in membrane biology, Vol 3. Plenum Press, New York, pp 81–146
Beck-Nielsen H, Pedersen O, Lindskov HO (1979) Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide. Acta Endocrinol (Copenh) 90: 451–462
Flatt PR, Bailey CJ (1981) Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice. Horm Metab Res 13: 556–560
Davidson MB, Kaplan SA (1977) Increased insulin binding by hepatic plasma membranes from diabetic rats. Normalization by insulin therapy. J Clin Invest 59: 22–30
Schoenic E, Zapf J, Froesch ER (1977) Effect of insulin and NSILA on adipocytes of normal and diabetic rats: receptor binding, glucose transport and glucose metabolism. Diabetologia 13: 243–249
Kasuga M, Akanuma Y, Iwamoto Y, Kosaka K (1978) Insulin binding and glucose metabolism in adipocytes of streptozotocindiabetic rats. Am J Physiol 235: E175-E182
Wieringa T, Krans HMJ (1978) Reduced glucose transport and increased binding of insulin in adipocytes from diabetic and fasted rats. Biochim Biophys Acta 538: 563–570
Duckworth WC, Gifford D, Kitabchi AE, Runyan K, Solomon SS (1979) Insulin binding and degradation by muscles from streptozotocin-diabetic rats. Diabetes 28: 746–748
Kobayashi M, Olefsky JM (1979) Effects of streptozotocin-induced diabetes on insulin binding, glucose transport, and intracellular glucose metabolism in isolated rat adipocytes. Diabetes 28: 87–95
Lord JM, White SI, Bailey CJ, Atkins TW, Fletcher RF, Taylor KG (1983) Effect of metformin on insulin receptor binding and glycaemic control in Type 2 diabetes. Br Med J 286: 830–831
Bailey CJ, Broadbent ME (1981) Chronic effects of glibenclamide, chlorpropamide and metformin on plasma glucose and insulin in non-diabetic rats. Gen Pharmacol 12: 323–326
Le Marchand-Brustel Y, Jeanrenaud B, Freychet P (1978) Insulin binding and effects of isolated soleus muscle of lean and obese mice. Am J Physiol 234: E348-E358
Grundleger ML, Godbole VY, Thenen SW (1980) Age-dependent development of insulin resistance of soleus muscle in genetically obese (ob/ob) mice. Am J Physiol 239: E363-E371
Kolterman OG, Gray RS, Griffin J, Burstein P, Insel J, Scarlett JA, Olefsky JM (1981) Receptor and post-receptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Invest 68: 957–969
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lord, J.M., Atkins, T.W. & Bailey, C.J. Effect of metformin on hepatocyte insulin receptor binding in normal, streptozotocin diabetic and genetically obese diabetic (ob/ob) mice. Diabetologia 25, 108–113 (1983). https://doi.org/10.1007/BF00250897
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00250897